Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study

SL Thrower; L James; W. Hall; KM Green; S Arif; JS Allen; C Van-Krinks; B Lozanoska-Ochser; LG Marquesini; S Brown; FS Wong; CM Dayan; M Peakman

Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study

SL Thrower
, L James
, W. Hall
, KM Green
, S Arif
, JS Allen
, C Van-Krinks
, B Lozanoska-Ochser
, LG Marquesini
, S Brown
, FS Wong
, CM Dayan
, M Peakman

Research output: Contribution to journal › Article (Academic Journal) › peer-review

138 Citations (Scopus)

Translated title of the contribution	Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study
Original language	English
Pages (from-to)	156 - 165
Number of pages	10
Journal	Clinical and Experimental Immunology
Volume	155
Publication status	Published - Feb 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Handle.net

Persistent link

Cite this

@article{84180d933a614fab9b8eddc20d741022,

title = "Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study",

author = "SL Thrower and L James and W. Hall and KM Green and S Arif and JS Allen and C Van-Krinks and B Lozanoska-Ochser and LG Marquesini and S Brown and FS Wong and CM Dayan and M Peakman",

year = "2009",

month = feb,

language = "English",

volume = "155",

pages = "156 -- 165",

journal = "Clinical and Experimental Immunology",

issn = "0009-9104",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study

AU - Thrower, SL

AU - James, L

AU - Hall, W.

AU - Green, KM

AU - Arif, S

AU - Allen, JS

AU - Van-Krinks, C

AU - Lozanoska-Ochser, B

AU - Marquesini, LG

AU - Brown, S

AU - Wong, FS

AU - Dayan, CM

AU - Peakman, M

PY - 2009/2

Y1 - 2009/2

M3 - Article (Academic Journal)

SN - 0009-9104

VL - 155

SP - 156

EP - 165

JO - Clinical and Experimental Immunology

JF - Clinical and Experimental Immunology

ER -